Cabozantinib for Metastatic RCC in Clinical Practice
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Cabozantinib Use in Metastatic Renal Cell Carcinoma Patients in Clinical Practice: Evaluation of Dosing Patterns, Tolerability, and Outcomes Compared to Clinical Trials
J Oncol Pharm Pract 2019 Sep 29;[EPub Ahead of Print], JH McElwee, TS Gourdin, J Mikoll, E Weeda, AM SionFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.